Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index; 18 of the 81 sources its claims cite were checked for support.

Individual psychotherapy for cluster-C personality disorders: protocol of a pragmatic RCT comparing short-term psychodynamic supportive psychotherapy, affect phobia therapy and schema therapy (I-FORCE)

Open access

Abstract

Background: Cluster-C personality disorders (PDs) are highly prevalent in clinical practice and are associated with unfavourable outcome and chronicity of all common mental health disorders (e.g. depression and anxiety disorders). Although several forms of individual psychotherapy are commonly offered in clinical practice for this population, evidence for differential effectiveness of different forms of psychotherapy is lacking. Also, very little is known about the underlying working mechanisms of these psychotherapies. Finding evidence on the differential (cost)-effectiveness for this group of patients and the working mechanisms of change is important to improve the quality of care for this vulnerable group of patients. Objective: In this study, we will compare the differential (cost)-effectiveness of three individual psychotherapies: short-term psychodynamic supportive psychotherapy (SPSP), affect phobia therapy (APT) and schema therapy (ST). Although these psychotherapies are commonly used in clinical practice, evidence for the Cluster-C PDs is limited. Additionally, we will investigate predictive factors, non-specific and therapy-specific mediators. Methods: This is a mono-centre randomized clinical trial with three parallel groups: (1) SPSP, (2) APT, (3) ST. Randomization on patient level will be pre-stratified according to type of PD. The total study population to be included consists of 264 patients with Cluster-C PDs or other specified PD with mainly Cluster-C traits, aged 18–65 years, seeking treatment at NPI, a Dutch mental health care institute specialized in PDs. SPSP, APT and ST (50 sessions per treatment) are offered twice a week in sessions of 50 min for the first 4 to 5 months. After that, session frequency decreases to once a week. All treatments have a maximum duration of 1 year. Change in the severity of the PD (ADP-IV) will be the primary outcome measure. Secondary outcome measures are personality functioning, psychiatric symptoms and quality of life. Several potential mediators, predictors and moderators of outcome are also assessed. The effectiveness study is complemented with a cost-effectiveness/utility study, using both clinical effects and quality-adjusted life-years, and primarily based on a societal approach. Assessments will take place at baseline, start of treatment and at 1, 3, 6, 9, 12, 18, 24 and 36 months. Discussion: This is the first study comparing psychodynamic treatment to schema therapy for Cluster-C PDs. The naturalistic design enhances the clinical validity of the outcome. A limitation is the lack of a control group for ethical reasons. Trial registration: NL72823.029.20 [Registry ID: CCMO]. Registered on 31 August 2020. First participant included on 23 October 2020. © 2023, The Author(s).

Overview

CoChat Summary

## TL;DR

This protocol describes I-FORCE, a mono-centre pragmatic RCT comparing three 50-session individual psychotherapies for Cluster-C personality disorders: short-term psychodynamic supportive psychotherapy (SPSP), affect phobia therapy (APT), and schema therapy (ST). It is designed to test differential effectiveness, cost-effectiveness, and treatment mechanisms in 264 patients aged 18–65 years.

## Key findings

  • The study is a protocol, so it does not report trial results.
  • The planned sample is 264 patients total, with 88 per arm, to detect a medium effect size (f = 0.11; equivalent to Cohen’s d = .492) with power = 0.80 and Bonferroni-corrected p = 0.0167.
  • Prior evidence summarized in the paper includes a multicentre study of N = 323, where schema therapy was superior to treatment-as-usual and clarification-oriented psychotherapy on interview-based outcome for mainly Cluster-C PD.
  • The authors state the trial will compare outcomes over 0 to 12 months, with follow-up at 18, 24, and 36 months, and will also assess cost-effectiveness using quality-adjusted life-years and societal costs.

## Methods

  • Design: Mono-centre, pragmatic randomized clinical trial with three parallel groups and 1:1:1 allocation; randomization is stratified by type of PD and location.
  • Sample/data: 264 patients with Cluster-C PD or otherwise specified PD with predominantly Cluster-C traits, aged 18–65, recruited at NPI in the Netherlands; treatments are 50 sessions over a maximum of 1 year.
  • Analysis: Primary and secondary outcomes will be analyzed under intention-to-treat using linear mixed models / mixed regression; moderators and mediators will be examined with regression, multilevel mediation, and structural equation models; cost-effectiveness will use multiple imputation and bootstrapping with 5000 replications.

## Limitations

  • The paper explicitly states there is no inactive control / no-treatment group, due to ethical reasons; the authors note this means the influence of natural course variation over time cannot be ruled out.
  • The authors state the sample may be more heterogeneous because it includes both full Cluster-C PD and otherwise specified PD with predominantly Cluster-C traits; this is a limitation stated in the paper, though they argue it improves clinical relevance.
  • The authors note they did not adjust the sample size for dropout, which might negatively impact power; this is a limitation stated in the paper.
  • Evident from the protocol: because this is a protocol, the paper contains planned methods but no outcome data yet.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13063-023-07136-z

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flow chart of the study design
Fig. 1 Flow chart of the study designCC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 9 Not valid · 44 Not checked · 73 Own results and interpretations

35 more claims · 3 with their cited sources checked

Create a free account to see all 143 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 85
  • It may state two separate claims as one. 39

Create a free account to see these claims.

Citations

Cites

Show all 99 references

Research works printed but not linked: 10

  1. Bernstein DP, Fink L. Childhood trauma questionnaire: a retrospective self-report. San Antonio: NCS Pearson; 1998.
  2. De Beurs E, Zitman F. De brief symptom inventory (BSI). De betrouwbaarheid en validiteit van een handzaam alternatief voor de SCL-90. Leiden: Leids universitair medisch centrum; 2005.
  3. de Ruiter H, van Dam Q. Affectfobietherapie in de praktijk. 2019. (2016). Amsterdam: Hogrefe, 220. Tijdschrift voor Psychotherapie, 45(4), 255.
  4. Doering S, Renn D, Hofer S, Rumpold G, Smrekar U, Janecke N, et al. Validation of the “assessment of DSM-IV personality disorders (ADP-IV)” questionnaire. Z Psychosom Med Psychother. 2007;53(2):111–28.
  5. Forster C, Berthollier N, Rawlinson D. A systematic review of potential mechanisms of change in psychotherapeutic interventions for personality disorder. J Psychol Psychother. 2014;4(133):2161–0487.
  6. Ingenhoven T, Poolen F, Berghuis H. The inventory of personality organisation: Dutch translation. Amersfoort: Psychiatrisch Centrum Symfora Groep; 2004.
  7. Kool M, Van R, Arntz A, Bartak A, Peen J, Dekker J. The effects of 25- versus 50- sessions in a year on psychotherapy outcome in patients with comorbid depression and personality disorders: a pragmatic randomized factorial trial; 2021. RINO concept article
  8. McCullough L, editor. Treating affect phobia: a manual for short-term dynamic psychotherapy: Guilford Press; 2003.
  9. Van Dam Q. Affectfobietherapie in de praktijk: Hogrefe Uitgevers Amsterdam; 2016.
  10. Van Hakkaart-van RL, Van Straten A, Donker M, Tiemens B. Trimbos/iMTA questionnaire for costs associated with psychiatric illness (TIC-P): Institute for Medical Technology Assessment; 2002.

Cited by

See all 9

Metadata

Authors
Daniëls, M., Van, H. L., van den Heuvel, B., Dekker, J. J. M., Peen, J., Bosmans, J., Arntz, A., & Huibers, M. J. H.
Affiliations
  • Arkin (NL)
  • Vrije Universiteit Amsterdam (NL)
  • Amsterdam Public Health (NL)
  • University of Amsterdam (NL)
  • Utrecht University (NL)
Corresponding author
Daniëls, Martine
Venue
Trials
Published
2023-04-05
Volume
24
Issue
1
Pages
260-260
ISSN
1745-6215 (ISSN-L)
OpenAlex
W4362603895
Cited by
9
References
99
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2
FWCI
2.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, cc-by)
  • UvA-DARE (University of Amsterdam) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
personality disorders, schema therapy, brief psychotherapy, cost-effectiveness, quality-adjusted life years, personality functioning, quality of life, psychiatric symptoms, psychotherapy comparison, non-specific treatment effects, treatment discontinuation, treatment acceptability
MeSH terms
Schema Therapy, Humans, Personality Disorders, Phobic Disorders, Psychotherapy, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome, Pragmatic Clinical Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individual psychotherapy for cluster-C personality disorders: protocol of a pragmatic RCT comparing short-term psychodynamic supportive psychotherapy, affect phobia therapy and schema therapy (I-FORCE). https://app.cochat.ai/papers/10.1186/s13063-023-07136-z
The paper
Daniëls, M., Van, H. L., van den Heuvel, B., Dekker, J. J. M., Peen, J., Bosmans, J., Arntz, A., & Huibers, M. J. H. (2023). Individual psychotherapy for cluster-C personality disorders: protocol of a pragmatic RCT comparing short-term psychodynamic supportive psychotherapy, affect phobia therapy and schema therapy (I-FORCE). Trials. https://doi.org/10.1186/s13063-023-07136-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.